Capricor Therapeutics (CAPR) Stock Highlights

18.92 | +2.49%

2024-11-21 03:59:16

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The companys development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Statistics

Range Today

18.22 19.39

Volume Today 818.2K

Range 1 Year

2.87 23.4

Volume 1 Year 263.78M

Range 3 Year

2.56 23.4

Volume 3 Year 353.03M

Range 10 Year

0.88 106.8

Volume 10 Year 1.22B

Highlights

Market Capitalization 894.5M (small)

Floating Shares 26.63M

Current Price 18.92

Price To Earnings -21.07

Price To Revenue 22.59

Price To Book 54.72

Earnings Per Share -0.89

Payout Ratio 0%

Performance

Latest +2.49%

1 Month +0.48%

3 Months +368.32%

6 Months +203.69%

1 Year +526.49%

3 Years +476.83%

5 Years +987.36%

10 Years -52.7%

Benchmarks

Market Capitalization

247 / 368

Gross Profits

118 / 278

Total Revenue

174 / 300

Total Rank

54 / 368

Free Cashflow

113 / 352

Performance 5 years

9 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.